MSAC Consultation Survey - Application 1785 - resubmission

Overview

A further period of consultation is open on application 1785 – Dexcom ONE+ Continuous Glucose Monitoring (CGM) System for people with insulin-dependent type 2 diabetes, for consideration by the Medical Services Advisory Committee (MSAC) and its Evaluation Subcommittee (ESC). Consultation input helps MSAC and its subcommittees to better understand how a proposed health service or technology fits in the Australian health care environment.

MSAC previously considered application 1785 – Dexcom ONE+ Continuous Glucose Monitoring System at its meeting on 31 July 2025. The application requested National Diabetes Services Scheme (NDSS) funding of the Dexcom ONE+ CGM system for people with insulin-dependent type 2 diabetes (T2D). The population was people aged ≥2 years with T2D requiring insulin who have sub-optimal glycaemic control confirmed by laboratory measured glycated haemoglobin (HbA1c) levels of >7.0% for adults and >6.5% for children and adolescents. Two subpopulations were defined:

• Subpopulation 1: Require treatment with basal insulin and rapid acting insulin
• Subpopulation 2: Require treatment with basal insulin only.

After considering the strength of the available evidence in relation to comparative safety, clinical effectiveness, cost-effectiveness and total cost, MSAC deferred its decision on public funding for this application, with a mind to support a resubmission if the applicant addresses the issues raised by MSAC. MSAC requested that more work is done to clearly identify the subgroups of people with type 2 diabetes who would gain the most benefit from CGM, and to fix problems with the economic model to ensure the results are reliable.

The Public Summary Document (PSD) for application 1785 sets out MSAC’s reasoning and concerns. You can view the PSD as a PDF document (right click on the link and select 'open link in new tab'). If you would prefer to view as a word document, go to the application webpage and scroll to the 'Application Documents' section, locate the PSD and select 'Download Word'. This will download the PSD to your device.  

How to provide input

This survey asks questions directly related to issues raised by MSAC in the PSD. You can give input to MSAC on these questions by completing the online survey. To help your preparation, you can download a copy of the questions asked in the survey. To do this, click on the 'Survey Questions' link below (under 'Related'). If you have trouble using the online survey, you can complete this Microsoft Word version and email to commentsMSAC@health.gov.au.

If you have previously provided consultation input on MSAC application 1785 – Dexcom ONE+ Continuous Glucose Monitoring System, ESC and MSAC will review this input again when they next consider this application. There is no need to give further input unless you want to comment on the specific questions in this survey.